The Whimsey Perch
Skip to content
TWP RESOURCES

Pharmaceuticals Case Studies

Technology, digital transformation and operational solutions for the pharmaceuticals industry.

Healthcare & Life Sciences

Pharmaceuticals

Technology, digital transformation and operational solutions for the pharmaceuticals industry.

← All Industries
DOCUMENTED EXAMPLES

25 global benchmark case studies

These are external public examples. They are not represented as TWP client projects.

PUBLICLY DOCUMENTED CASE

Roche — digital transformation in pharma R&D

Roche · Switzerland
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Roche example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Novartis — data and AI-driven drug development

Novartis · Switzerland
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Novartis example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Pfizer — digital manufacturing and analytics

Pfizer · United States
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Pfizer example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

AstraZeneca — AI and data science in R&D

AstraZeneca · United Kingdom
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The AstraZeneca example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Sanofi — AI-enabled drug discovery and operations

Sanofi · France
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Sanofi example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

GSK — data and AI transformation

GSK · United Kingdom
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The GSK example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Merck KGaA — digital manufacturing and R&D

Merck KGaA · Germany
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Merck KGaA example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Johnson & Johnson — connected manufacturing and quality

Johnson & Johnson · United States
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Johnson & Johnson example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Eli Lilly — digital manufacturing and smart factories

Eli Lilly · United States
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Eli Lilly example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Bayer — digital farming and pharma data platforms

Bayer · Germany
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Bayer example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Boehringer Ingelheim — AI and digital R&D

Boehringer Ingelheim · Germany
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Boehringer Ingelheim example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Takeda — digital patient and R&D platforms

Takeda · Japan
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Takeda example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Otsuka — digital health and pharma innovation

Otsuka Pharmaceutical · Japan
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Otsuka Pharmaceutical example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Daiichi Sankyo — data-driven R&D

Daiichi Sankyo · Japan
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Daiichi Sankyo example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Sun Pharma — digital manufacturing and supply chain

Sun Pharma · India
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Sun Pharma example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Cipla — digital quality and manufacturing

Cipla · India
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Cipla example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Dr Reddy’s — digital supply chain and analytics

Dr. Reddy’s Laboratories · India
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Dr. Reddy’s Laboratories example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Biocon — digital biomanufacturing and analytics

Biocon · India
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Biocon example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Serum Institute — digital manufacturing and quality systems

Serum Institute of India · India
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Serum Institute of India example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Moderna — digital mRNA manufacturing and R&D

Moderna · United States
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Moderna example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

BioNTech — digitalized vaccine development

BioNTech · Germany
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The BioNTech example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Gilead Sciences — data-driven clinical development

Gilead Sciences · United States
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Gilead Sciences example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Amgen — AI and advanced analytics in biopharma

Amgen · United States
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Amgen example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

Pfizer — AI-enabled clinical trial operations

Pfizer · United States
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The Pfizer example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
PUBLICLY DOCUMENTED CASE

FDA — regulatory science and AI use cases

U.S. FDA · United States
Challenge

The organisation needed to improve research, clinical development, manufacturing, quality, supply chain or commercial workflows using data and digital technologies.

Solution

Data platforms, AI, digital labs, connected manufacturing, quality systems, clinical technologies or supply-chain platforms were applied across the value chain.

AI/MLClinical dataDigital manufacturingQuality systemsSupply chain
Documented results / capabilities
  • The linked primary/official case-study collection documents the organisation and technology initiative.
  • This record intentionally does not add performance figures that are not directly supported by the linked source.
India relevance

The U.S. FDA example illustrates a technology pattern that can be adapted to Indian organisations facing similar scale, integration, governance or workflow challenges.

TWP custom-software opportunity

TWP can use the documented pattern as a starting point for a custom solution for an Indian organisation: discovery and process mapping, custom web/mobile software, APIs and integrations, workflow automation, dashboards, AI/data capabilities, security and ongoing optimisation.

Evidence note: Primary or official case-study collection evidence. This record is descriptive; it does not imply that the linked organisation is a TWP client or that TWP delivered the referenced implementation.
RESEARCH SNAPSHOT

Industry insights

Each research document opens its verified public source.

VERIFIED PUBLIC SOURCE

Pharmaceuticals: global technology pattern 01

Public case-study evidence for Roche demonstrates a documented use of digital technology to address a real operational requirement in the Pharmaceuticals domain.

Period: Publicly documented case-study evidence; reviewed 2026-09-22
Open research document ↗
VERIFIED PUBLIC SOURCE

Pharmaceuticals: global technology pattern 02

Public case-study evidence for Novartis demonstrates a documented use of digital technology to address a real operational requirement in the Pharmaceuticals domain.

Period: Publicly documented case-study evidence; reviewed 2026-09-22
Open research document ↗
VERIFIED PUBLIC SOURCE

Pharmaceuticals: global technology pattern 03

Public case-study evidence for Pfizer demonstrates a documented use of digital technology to address a real operational requirement in the Pharmaceuticals domain.

Period: Publicly documented case-study evidence; reviewed 2026-09-22
Open research document ↗
VERIFIED PUBLIC SOURCE

Pharmaceuticals: global technology pattern 04

Public case-study evidence for AstraZeneca demonstrates a documented use of digital technology to address a real operational requirement in the Pharmaceuticals domain.

Period: Publicly documented case-study evidence; reviewed 2026-09-22
Open research document ↗
VERIFIED PUBLIC SOURCE

Pharmaceuticals: global technology pattern 05

Public case-study evidence for Sanofi demonstrates a documented use of digital technology to address a real operational requirement in the Pharmaceuticals domain.

Period: Publicly documented case-study evidence; reviewed 2026-09-22
Open research document ↗
VERIFIED PUBLIC SOURCE

Pharmaceuticals: global technology pattern 06

Public case-study evidence for GSK demonstrates a documented use of digital technology to address a real operational requirement in the Pharmaceuticals domain.

Period: Publicly documented case-study evidence; reviewed 2026-09-22
Open research document ↗
VERIFIED PUBLIC SOURCE

Pharmaceuticals: global technology pattern 07

Public case-study evidence for Merck KGaA demonstrates a documented use of digital technology to address a real operational requirement in the Pharmaceuticals domain.

Period: Publicly documented case-study evidence; reviewed 2026-09-22
Open research document ↗
VERIFIED PUBLIC SOURCE

Pharmaceuticals: global technology pattern 08

Public case-study evidence for Johnson & Johnson demonstrates a documented use of digital technology to address a real operational requirement in the Pharmaceuticals domain.

Period: Publicly documented case-study evidence; reviewed 2026-09-22
Open research document ↗
VERIFIED PUBLIC SOURCE

Pharmaceuticals: global technology pattern 09

Public case-study evidence for Eli Lilly demonstrates a documented use of digital technology to address a real operational requirement in the Pharmaceuticals domain.

Period: Publicly documented case-study evidence; reviewed 2026-09-22
Open research document ↗
VERIFIED PUBLIC SOURCE

Pharmaceuticals: global technology pattern 10

Public case-study evidence for Bayer demonstrates a documented use of digital technology to address a real operational requirement in the Pharmaceuticals domain.

Period: Publicly documented case-study evidence; reviewed 2026-09-22
Open research document ↗
VERIFIED PUBLIC SOURCE

Pharmaceuticals: global technology pattern 11

Public case-study evidence for Boehringer Ingelheim demonstrates a documented use of digital technology to address a real operational requirement in the Pharmaceuticals domain.

Period: Publicly documented case-study evidence; reviewed 2026-09-22
Open research document ↗
VERIFIED PUBLIC SOURCE

Pharmaceuticals: global technology pattern 12

Public case-study evidence for Takeda demonstrates a documented use of digital technology to address a real operational requirement in the Pharmaceuticals domain.

Period: Publicly documented case-study evidence; reviewed 2026-09-22
Open research document ↗
TWP TRANSFORMATION

Have an operational challenge?

Let's explore how technology can help you solve it.

Talk to an Expert →